Risk Factors Associated With 90-Day Recurrent Stroke in Patients on Dual Antiplatelet Therapy for Minor Stroke or High-Risk TIA: A Subgroup Analysis of the CHANCE Trial
Stroke and Vascular Neurology - United Kingdom
doi 10.1136/svn-2017-000088
Full Text
Open PDFAbstract
Available in full text
Date
July 6, 2017
Authors
Publisher
BMJ